483 NATCO Pharma Mar 2016

483 NATCO Pharma Mar 2016

Daniel Roberts FDA$119.00 - Available Now

FDA investigators audited the NATCO Pharma - Rangareddy, India facility and issued inspectional observations (via FDA 483) on 07 Mar 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 07 Mar 2016
  • Location: Rangareddy, India
  • FEI: 3004540906
Add To Cart